Form 4: PDS Biotechnology Director Acquires Shares and Warrants in Recent Transaction

Gregory Gene Freitag, a director at PDS Biotechnology Corp, recently acquired shares and warrants of the company's common stock.

Summary

• On February 28, 2025, Gregory Gene Freitag, a director of PDS Biotechnology Corp, acquired 15,060 shares of common stock at a price of $1.66 per share.
• Following this transaction, Freitag directly owns 61,213 shares of common stock.
• Freitag also acquired a common warrant to purchase 15,060 shares of common stock with an exercise price of $1.53, expiring on February 28, 2030.
• The purchase price for the common warrant is included in the purchase price for the shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (directors, officers, or those holding 10% or more of a company's shares) trade in their company's stock. These filings provide transparency to the market regarding insider activity.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates